Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
$1.05
$1.41
$1.04
$8.96
N/AN/A2,590 shsN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
C$10.60
-3.8%
C$10.60
C$3.50
C$15.75
C$168.68MN/A12,671 shs3,402 shs
DNX
Dynex Power
C$0.64
+∞
C$0.64
C$0.11
C$0.65
C$51.53MN/A91,448 shs2,500 shs
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
$10.18
$10.19
$10.01
$13.17
$254.50M0.17192,412 shs1.76 million shs
PTK
PTK Acquisition
$9.23
$7.40
$11.34
$101.50MN/A82,948 shs1.40 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
0.00%0.00%-12.50%-48.78%-84.47%
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.00%0.00%0.00%0.00%0.00%
DNX
Dynex Power
0.00%0.00%0.00%0.00%0.00%
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
0.00%0.00%0.00%0.00%0.00%
PTK
PTK Acquisition
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
0.0153 of 5 stars
0.00.00.80.00.00.01.3
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
DNX
Dynex Power
N/AN/AN/AN/AN/AN/AN/AN/A
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
PTK
PTK Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
1.00
SellN/AN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AN/AN/A
DNX
Dynex Power
N/AN/AN/AN/A
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
N/AN/AN/AN/A
PTK
PTK Acquisition
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
N/AN/AN/AN/AN/AN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AC$3.34 per share3.17C$3.60 per shareN/A
DNX
Dynex Power
C$42.30M1.22C$0.03 per share18.82C$0.28 per share2.32
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
N/AN/AN/AN/A($0.69) per shareN/A
PTK
PTK Acquisition
N/AN/AN/AN/A$0.35 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
N/A$1.300.81N/AN/AN/AN/AN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A-C$0.38N/AN/AN/AN/AN/AN/A
DNX
Dynex Power
N/A-C$0.06N/AN/AN/AN/AN/AN/A
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
-$40.56MN/A0.00N/AN/A-70.91%19.85%N/A
PTK
PTK Acquisition
-$2.45MN/A0.00N/AN/AN/A-89.10%-3.86%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
$0.2119.81%N/A16.00%N/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/AN/AN/AN/AN/A
DNX
Dynex Power
N/AN/AN/AN/AN/A
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
N/AN/AN/AN/AN/A
PTK
PTK Acquisition
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
N/AN/AN/A
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
0.05
129.63
128.68
DNX
Dynex Power
109.97
0.83
0.43
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
N/A
0.70
0.70
PTK
PTK Acquisition
N/A
0.02
0.02

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
38.13%
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
N/A
DNX
Dynex Power
N/A
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
50.59%
PTK
PTK Acquisition
69.26%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ams-OSRAM AG stock logo
AUKUF
ams-OSRAM
20,000N/AN/ANot Optionable
BriaCell Therapeutics Corp. stock logo
BCT
BriaCell Therapeutics
515.91 millionN/ANot Optionable
DNX
Dynex Power
33780.51 millionN/ANot Optionable
FAST Acquisition Corp. stock logo
FST
FAST Acquisition
N/A25.00 million24.69 millionNot Optionable
PTK
PTK Acquisition
313.11 millionN/ANot Optionable

PTK, DNX, FST, AUKUF, and BCT Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

ams-OSRAM logo

ams-OSRAM

OTCMKTS:AUKUF
ams-OSRAM AG designs, manufactures, and sells LED and optical sensor solutions in Europe, the Middle East, Africa, the Americas, and Asia/Pacific. The company operates in Semiconductors and Lamps & Systems segments. The Semiconductors segment offers semiconductor-based products and solutions, such as high-performance LEDs, lasers, and optical sensors for automotive, consumer, and industrial end markets. The Lamps & Systems segment provides lamps and lighting systems for the automotive, industrial, and medical end markets. The company was formerly known as ams AG and changed its name to ams-OSRAM AG in January 2022. ams-OSRAM AG was founded in 1981 and is headquartered in Premstätten, Austria.
BriaCell Therapeutics logo

BriaCell Therapeutics

CVE:BCT
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Dynex Power

CVE:DNX
Dynex Power Inc., through its subsidiary, Dynex Semiconductor Limited, designs, manufactures, and sells industrial power equipment worldwide. The company's products include high power bipolar discrete semiconductors, high power insulated gate bipolar transistor modules and dies, and high power electronic assemblies and components. Its products are used by electronic equipment manufacturers and maintenance providers in various sectors, including railway propulsion and on-board systems; industrial electric power transmission and distribution, renewable and distributed power, heavy industries, and factory automation; marine propulsion and on-board systems; aircraft power electronic systems; and electric vehicles. The company was founded in 1956 and is based in Kanata, Canada. Dynex Power Inc. is a subsidiary of Zhuzhou CRRC Times Electric Co., Ltd.
FAST Acquisition logo

FAST Acquisition

NYSE:FST
FAST Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in restaurant, hospitality, and related sectors. FAST Acquisition Corp. was incorporated in 2020 and is based in Ridgefield, Connecticut.

PTK Acquisition

NYSE:PTK
PTK Acquisition Corp. does not have significant operations. It focuses on entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2019 and is based in Los Angeles, California.